- Disease: Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Prospective, Single centre
- Objective: To assess pregnant women’s adherence to current infant RSV prevention strategies in France, focusing on the option most commonly chosen (either maternal vaccination with Abrysvo® during pregnancy or neonatal administration of Beyfortus®) and to identify factors influencing the choice between strategies, as well as the main reasons women report for adopting or not adopting each strategy
- Number of participants enrolled: Enrollment data not available
- Study enrolling from to
- Study includes follow-up for 6 months
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Pregnant women
- Hospital
- Outpatient clinic
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Vaccination
- Nirsevimab
- Abrysvo
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to